Related Experiment Video

Updated: Aug 2, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Blood glucose control and compliance of diabetic children

F P de Villiers1, E Chester, K E Meyers

  • 1Department of Paediatrics & Child Health, MEDUNSA, Johannesburg Hospital.

Curationis
|July 1, 1997
PubMed

Insights

Poor adherence to diabetes management in children is linked to suboptimal glycemic control. Key issues include infrequent blood glucose monitoring and incorrect insulin injection timing, impacting overall diabetes care.

Area of Science:

  • Pediatric Endocrinology
  • Diabetes Management

Background:

  • Non-compliance significantly impedes effective diabetes management in pediatric patients.
  • Identifying specific areas of non-adherence is crucial for improving glycemic control.

Purpose of the Study:

  • To pinpoint specific aspects of non-compliance within the diabetes management regimen among children attending a pediatric diabetes clinic.

Main Methods:

  • A questionnaire-based study involving 57 pediatric patients at a diabetes clinic.
  • Patients were categorized by glycemic control (well, satisfactory, poor) based on glycosylated hemoglobin levels.
  • Data collected included socio-demographic information and adherence to the diabetic regimen.

Main Results:

  • Poorly controlled children monitored blood glucose less frequently (≤ twice daily) compared to well-controlled peers (≥ thrice daily).
  • Incorrect insulin injection timing was common; 42% of patients had prior hospital admissions.
  • Over 60% did not correlate blood glucose testing with exercise; poorly controlled patients were older, had longer diabetes duration, and lived further from the clinic.

Conclusions:

  • Suboptimal glycemic control in pediatric diabetes is associated with specific non-adherence behaviors.
  • Targeted interventions addressing monitoring frequency, injection timing, and exercise-related testing are needed.
  • Patient age, diabetes duration, and proximity to the clinic may influence adherence and control.
Abstract

More Related Videos

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice07:35

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Published on: January 26, 2024

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection06:11

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection

Published on: May 17, 2024

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...